Llinás M T, López R, Rodríguez F, Roig F, Salazar F J
Department of Physiology, School of Medicine, University of Murcia, 30100 Murcia, Spain.
Am J Physiol Renal Physiol. 2001 Nov;281(5):F975-82. doi: 10.1152/ajprenal.2001.281.5.F975.
The objective of this study was to examine the role of cylcooxygenase (COX)-2-derived prostaglandins (PG) in modulating the renal hemodynamic effects of norepinephrine (NE) during low or normal sodium intake. The relative contribution of each COX isoform in producing the PG that attenuate the renal NE effects during normal sodium intake was also evaluated. The renal response to three doses of NE (50, 100, and 250 ng. kg(-1). min(-1)) was evaluated in anesthetized dogs pretreated with vehicle, a selective COX-2 inhibitor (nimesulide), or a nonselective COX inhibitor (meclofenamate). Intrarenal infusion of the two lower doses of NE in vehicle-pretreated dogs with normal sodium intake (n = 8) elicited an increase in renal vascular resistance (RVR; 21 and 34%) without inducing changes in glomerular filtration rate (GFR). The highest dose of NE in this group induced a further increment in RVR (113%) and a decrease in GFR (33%). Pretreatment with nimesulide in dogs with normal sodium intake (n = 7) did not modify the NE-induced increments in RVR but enhanced the decreases in GFR induced by the three NE doses (12, 26, and 64%). The renal hemodynamic response to NE in meclofenamate-pretreated dogs with normal sodium intake (n = 7) was similar to that found in dogs pretreated with nimesulide. Infusion of the lowest dose of NE to vehicle-pretreated dogs with low sodium intake (n = 6) did not modify GFR and elicited an increase in RVR (42%). Infusion of the second and third doses of NE led to a decrease in GFR (35 and 91%) and a rise in RVR (82 and 587%). Infusion of the first two doses of NE in nimesulide-pretreated dogs with low sodium intake (n = 5) induced a fall in GFR (64 and 92%) and an increase in RVR (174 and 2,293%) that were greater (P < 0.05) than those induced by NE in vehicle-pretreated dogs. The elevation in the urinary excretion rates of PGE(2) and 6-keto-PGF(1alpha) elicited by NE was prevented in the nimesulide-pretreated dogs. Our results show that COX-2 inhibition potentiates the renal hemodynamic effects of NE and propose that the PG involved in modulating them are mainly derived from COX-2 activity.
本研究的目的是探讨环氧化酶(COX)-2衍生的前列腺素(PG)在低钠或正常钠摄入期间调节去甲肾上腺素(NE)的肾血流动力学效应中的作用。还评估了在正常钠摄入期间,每种COX同工型在产生减弱肾NE效应的PG中的相对贡献。在用溶媒、选择性COX-2抑制剂(尼美舒利)或非选择性COX抑制剂(甲氯芬那酸)预处理的麻醉犬中,评估了对三种剂量NE(50、100和250 ng·kg⁻¹·min⁻¹)的肾反应。在正常钠摄入的溶媒预处理犬(n = 8)中,肾内输注两种较低剂量的NE会引起肾血管阻力(RVR)增加(21%和34%),而不会引起肾小球滤过率(GFR)的变化。该组中最高剂量的NE会使RVR进一步增加(113%),并使GFR降低(33%)。在正常钠摄入的犬(n = 7)中用尼美舒利预处理,不会改变NE诱导的RVR增加,但会增强三种NE剂量诱导的GFR降低(12%、26%和64%)。在正常钠摄入的甲氯芬那酸预处理犬(n = 7)中,对NE的肾血流动力学反应与尼美舒利预处理犬相似。向低钠摄入的溶媒预处理犬(n = 6)输注最低剂量的NE不会改变GFR,并引起RVR增加(42%)。输注第二和第三剂量的NE会导致GFR降低(35%和91%)和RVR升高(82%和587%)。在低钠摄入的尼美舒利预处理犬(n = 5)中输注前两剂量的NE会导致GFR降低(64%和92%)和RVR增加(174%和2293%),比溶媒预处理犬中NE诱导的变化更大(P < 0.05)。在尼美舒利预处理犬中,NE引起的PGE₂和6-酮-PGF₁α尿排泄率升高被阻止。我们的结果表明,COX-2抑制增强了NE的肾血流动力学效应,并提出参与调节这些效应的PG主要源自COX-2活性。